Unemployed people to be given weight loss jabs to ‘get them back to work’ --[Reported by Umva mag]

Wes Streeting said ‘widening waistbands’ were placing a burden on the NHS.

Oct 15, 2024 - 06:36
Unemployed people to be given weight loss jabs to ‘get them back to work’ --[Reported by Umva mag]
SYDNEY, AUSTRALIA - OCTOBER 10: Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood sugar. While some doctors are prescribing it
Up to 3,000 obese patients will take part in a five-year study to investigate if the jabs increase productivity and bring people back to work (Picture: Corbis vis Getty)

Unemployed people could be given new weight loss jabs to help them get back into work, the Health Secretary has suggested.

Wes Streeting said ‘widening waistbands’ were placing a burden on the NHS.

He went on: ‘Our widening waistbands are also placing significant burden on our health service, costing the NHS £11 billion a year – even more than smoking. And it’s holding back our economy.

‘Illness caused by obesity causes people to take an extra four sick days a year on average, while many others are forced out of work altogether.’

Mr Streeting suggested the new class of weight loss medicine – like Ozempic or Mounjaro – could be administered to help get people working again and to ease costs to the health service, he added.

Up to 3,000 obese patients, including a mix of people with and without jobs, as well as some on sick leave, will take part in a five-year study to investigate if the jabs increase productivity and bring people back to work.

Mr Streeting’s suggestion, in a Telegraph newspaper opinion piece, comes as the Government announced a £279 million investment from Lilly – the world’s largest pharmaceutical company – on the day the Prime Minister hosted an international investment summit.

The plans announced at the summit will include real-world trials of weight loss jabs’ impact on worklessness, according to the Telegraph.

LONDON, UNITED KINGDOM OCTOBER 08, 2024: Secretary of State for Health and Social Care Wes Streeting arrives in Downing Street to attend the weekly Cabinet meeting in London, United Kingdom on October 08, 2024. (Photo credit should read Wiktor Szymanowicz/Future Publishing via Getty Images)
Mr Streeting’s suggestion comes as the Government announced a £279 million investment from Lilly – the world’s largest pharmaceutical company (Picture: Future Publishing via Getty)

A study by Health Innovation Manchester and Lilly, will examine whether being put on the drugs will reduce worklessness and the impact on NHS service use, and will take place in Greater Manchester.

The Health Secretary continued: ‘The reforms this Government will put in place will open the NHS up to work much more closely with life sciences, to develop new, more effective treatments, and put NHS patients at the front of the queue.

‘The long-term benefits of these drugs could be monumental in our approach to tackling obesity. For many people, these weight-loss jabs will be life-changing, help them get back to work, and ease the demands on our NHS.’

However, Mr Streeting insisted individuals will still need to remain responsible for taking ‘healthy living more seriously’, as the ‘NHS can’t be expected to always pick up the tab for unhealthy lifestyles’.

Get in touch with our news team by emailing us at webnews@metro.co.uk.

For more stories like this, check our news page.




The following news has been carefully analyzed, curated, and compiled by Umva Mag from a diverse range of people, sources, and reputable platforms. Our editorial team strives to ensure the accuracy and reliability of the information we provide. By combining insights from multiple perspectives, we aim to offer a well-rounded and comprehensive understanding of the events and stories that shape our world. Umva Mag values transparency, accountability, and journalistic integrity, ensuring that each piece of content is delivered with the utmost professionalism.